Samjin Pharmaceutical Co Ltd
KRX:005500
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
KR |
|
N
|
NeoVolta Inc
NASDAQ:NEOV
|
US |
|
Margun Enerji Uretim Sanayi ve Ticaret AS
IST:MAGEN.E
|
TR |
|
H
|
Henan Shijia Photons Technology Co Ltd
SSE:688313
|
CN |
|
A
|
ARC Resources Ltd
OTC:AETUF
|
CA |
|
Mamiya-OP Co Ltd
TSE:7991
|
JP |
|
C
|
Cbrain A/S
XBER:C6F
|
DK |
Wall Street
Price Targets
Price Targets Summary
Samjin Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Samjin Pharmaceutical Co Ltd is 24 480 KRW with a low forecast of 24 240 KRW and a high forecast of 25 200 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Samjin Pharmaceutical Co Ltd's stock price target?
Price Target
24 480
KRW
According to Wall Street analysts, the average 1-year price target for Samjin Pharmaceutical Co Ltd is 24 480 KRW with a low forecast of 24 240 KRW and a high forecast of 25 200 KRW.
What is Samjin Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
4%
For the last 13 years the compound annual growth rate for Samjin Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 4%.
What is Samjin Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the compound annual growth rate for Samjin Pharmaceutical Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 0%.
What is Samjin Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-17%
For the last 13 years the compound annual growth rate for Samjin Pharmaceutical Co Ltd's net income is 14%. The projected CAGR for the next 3 years is -17%.
